SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-13-002275
Filing Date
2013-03-04
Accepted
2013-03-04 16:13:44
Documents
16
Period of Report
2013-03-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ipxl20130301_8k.htm 8-K 29091
2 EXHIBIT 99.1 ipxl20130301_8k8k-1.htm EX-99 14845
3 EXHIBIT 99.2 ipxl20130301_8kex99-2.htm EX-99 7750
4 ipxl20130301_8k8k-1img001.gif GRAPHIC 3697
5 a12.jpg GRAPHIC 212220
6 a11.jpg GRAPHIC 402840
7 a10.jpg GRAPHIC 427436
8 a9.jpg GRAPHIC 405004
9 a8.jpg GRAPHIC 481003
10 a7.jpg GRAPHIC 442602
11 a6.jpg GRAPHIC 433954
12 a5.jpg GRAPHIC 401430
13 a4.jpg GRAPHIC 432172
14 a3.jpg GRAPHIC 368562
15 a2.jpg GRAPHIC 361782
16 a1.jpg GRAPHIC 405214
  Complete submission text file 0001437749-13-002275.txt   6637208
Mailing Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544 510-240-6000
IMPAX LABORATORIES INC (Filer) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34263 | Film No.: 13661801
SIC: 2834 Pharmaceutical Preparations